Shenzhen BioX Medical Co., Ltd. is a professional manufacturer specializing in molecular diagnostic analysis systems, genetic testing solutions, and clinical laboratory equipment. Established in 2017, the company is headquartered in Shenzhen, China, a leading center for biotechnology innovation, medical device development, and advanced manufacturing.
With a modern manufacturing facility covering more than 9,000 square meters and a workforce of over 200 employees, BioX Medical is dedicated to the research, development, production, and supply of molecular diagnostic technologies for clinical laboratories, hospitals, research institutions, public health organizations, and biotechnology companies worldwide.
The company's product portfolio includes molecular diagnostic analysis systems, nucleic acid testing platforms, genetic analysis systems, pathogen detection solutions, biomarker analysis equipment, automated laboratory testing systems, and precision medicine support technologies. By integrating advanced automation, data management capabilities, and laboratory workflow optimization, BioX Medical develops solutions designed to improve testing efficiency, analytical accuracy, and operational reliability.
The core of modern chronic disease management (CDM) lies in early molecular detection. Our qPCR and Nucleic Acid Extraction systems allow for the identification of genetic markers associated with metabolic disorders, cancer, and hereditary cardiovascular conditions long before clinical symptoms appear.
Transitioning from manual labs to "Smart Labs." We integrate AI-driven data analysis into our diagnostic platforms to provide predictive insights, reducing human error in complex biomarker analysis and improving the Information Gain for clinicians.
The future involves "Always-On" diagnostics. By combining laboratory-grade precision with structural integrity analysis and real-time displacement systems, we are exploring the intersection of biological monitoring and environment-assisted health tracking.
As the global burden of chronic diseases (Diabetes, COPD, Hypertension) increases, the demand for decentralized diagnostic tools and high-throughput screening has surged. China's role as a primary exporter of these tools is pivotal. We offer macro-solutions that integrate 4K laparoscopic imaging with genetic screening, allowing for a 360-degree view of patient health.
Our solutions cater to the "Triple Aim" of healthcare: improving the patient experience, improving the health of populations, and reducing the per capita cost of healthcare. By leveraging China's advanced manufacturing ecosystem, we provide cost-effective yet high-precision tools that are essential for national health screening programs in emerging markets.
Utilizing high-precision Z-lift platforms and automated assembly lines to ensure every diagnostic kit meets ISO 13485 standards. Our facility in Shenzhen utilizes IoT tracking for every batch produced.
Located in the heart of the Greater Bay Area, we enjoy unparalleled access to global logistics hubs, ensuring that our molecular diagnostic tools reach Europe or North America with minimal lead times.
We provide flexible manufacturing services for global distributors, allowing for localized software interfaces, customized reagent formulations, and branded hardware designs.
Navigating the complex landscape of medical device regulation is a core competency of BioX Medical. We provide comprehensive documentation support including CE Marking, ISO Certifications, and regional compliance data for various jurisdictions across Asia-Pacific and Latin America.
For global procurement officers, the "Information Gain" from our white papers lies in our transparent reporting of analytical sensitivity, specificity, and LOD (Limit of Detection) data. This allows for rigorous comparison against traditional Western brands, often proving that Shenzhen-made diagnostic tools offer equal or superior performance at a significantly lower TCO (Total Cost of Ownership).
Committed to advancing modern laboratory technologies, BioX Medical focuses on delivering reliable, scalable, and innovative diagnostic systems that support disease detection, genetic analysis, clinical research, and precision healthcare initiatives. Through continuous technological advancement and customer-oriented development, the company strives to contribute to the global evolution of molecular diagnostics and laboratory medicine.
Our commitment to E-E-A-T (Experience, Expertise, Authoritativeness, and Trustworthiness) is reflected in every instrument we ship. From the precision of our 96-well qPCR systems to the robustness of our veterinary diagnostic kits, BioX Medical is your trusted partner for the next generation of chronic disease management tools.
BioX Medical
